Page last updated: 2024-08-25

methyl 2,4-dihydroxy-3,6-dimethyl benzoate and Invasiveness, Neoplasm

methyl 2,4-dihydroxy-3,6-dimethyl benzoate has been researched along with Invasiveness, Neoplasm in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baniahmad, A; Claessens, F; Degen, S; Matusch, R; Papaioannou, M; Prade, I; Roell, D; Schleich, S; Schubert, U; Tanner, T1

Other Studies

1 other study(ies) available for methyl 2,4-dihydroxy-3,6-dimethyl benzoate and Invasiveness, Neoplasm

ArticleYear
The natural compound atraric acid is an antagonist of the human androgen receptor inhibiting cellular invasiveness and prostate cancer cell growth.
    Journal of cellular and molecular medicine, 2009, Volume: 13, Issue:8B

    Topics: Androgen Antagonists; Androgen Receptor Antagonists; Base Sequence; Cell Division; Cell Line, Tumor; DNA Primers; Humans; Hydroxybenzoates; Male; Neoplasm Invasiveness; Polymerase Chain Reaction; Prostatic Neoplasms

2009